دورية أكاديمية
Caffeine intake by patients with autosomal dominant polycystic kidney disease.
| العنوان: | Caffeine intake by patients with autosomal dominant polycystic kidney disease. |
|---|---|
| المؤلفون: | Vendramini LC; Disciplina de Nefrologia, Departamento de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil., Nishiura JL, Baxmann AC, Heilberg IP |
| المصدر: | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas [Braz J Med Biol Res] 2012 Sep; Vol. 45 (9), pp. 834-40. Date of Electronic Publication: 2012 Jul 19. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Associação Brasileira de Divulgação Científica Country of Publication: Brazil NLM ID: 8112917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1414-431X (Electronic) Linking ISSN: 0100879X NLM ISO Abbreviation: Braz J Med Biol Res Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [SP, Brasil : Associação Brasileira de Divulgação Científica, 1981- |
| مواضيع طبية MeSH: | Caffeine/*adverse effects , Kidney/*drug effects , Polycystic Kidney, Autosomal Dominant/*etiology, Adult ; Analysis of Variance ; Body Mass Index ; Caffeine/administration & dosage ; Case-Control Studies ; Cross-Sectional Studies ; Diet Records ; Female ; Humans ; Kidney/diagnostic imaging ; Kidney/pathology ; Male ; Organ Size/drug effects ; Polycystic Kidney, Autosomal Dominant/diagnostic imaging ; Polycystic Kidney, Autosomal Dominant/pathology ; Ultrasonography |
| مستخلص: | Because caffeine may induce cyst and kidney enlargement in autosomal dominant polycystic kidney disease (ADPKD), we evaluated caffeine intake and renal volume using renal ultrasound in ADPKD patients. Caffeine intake was estimated by the average of 24-h dietary recalls obtained on 3 nonconsecutive days in 102 ADPKD patients (68 females, 34 males; 39 ± 12 years) and compared to that of 102 healthy volunteers (74 females, 28 males; 38 ± 14 years). The awareness of the need for caffeine restriction was assessed. Clinical and laboratory data were obtained from the medical records of the patients. Mean caffeine intake was significantly lower in ADPKD patients versus controls (86 vs 134 mg/day), and 63% of the ADPKD patients had been previously aware of caffeine restriction. Caffeine intake did not correlate with renal volume in ADPKD patients. There were no significant differences between the renal volumes of patients in the highest and lowest tertiles of caffeine consumption. Finally, age-adjusted multiple linear regression revealed that renal volume was associated with hypertension, chronic kidney disease stage 3 and the time since diagnosis, but not with caffeine intake. The present small cross-sectional study indicated a low level of caffeine consumption by ADPKD patients when compared to healthy volunteers, which was most likely due to prior awareness of the need for caffeine restriction. Within the range of caffeine intake observed by ADPKD patients in this study (0-471 mg/day), the renal volume was not directly associated with caffeine intake. |
| References: | Food Chem Toxicol. 1996 Jan;34(1):119-29. (PMID: 8603790) Am J Kidney Dis. 2005 Dec;46(6):1058-64. (PMID: 16310571) J Am Soc Nephrol. 2009 Jan;20(1):205-12. (PMID: 18945943) Clin J Am Soc Nephrol. 2008 Jul;3(4):1212-8. (PMID: 18434616) Kidney Int. 2005 Jun;67(6):2089-100. (PMID: 15882252) Clin J Am Soc Nephrol. 2010 Apr;5(4):693-7. (PMID: 20167686) Kidney Int. 2004 Sep;66(3):964-73. (PMID: 15327388) J Am Soc Nephrol. 2006 Aug;17(8):2220-7. (PMID: 16807403) Ann Intern Med. 1999 Mar 16;130(6):461-70. (PMID: 10075613) Clin J Am Soc Nephrol. 2009 Apr;4(4):838-44. (PMID: 19339428) Am J Clin Nutr. 2008 Aug;88(2):324-32. (PMID: 18689367) Am J Kidney Dis. 2002 Jun;39(6):1127-34. (PMID: 12046022) Adv Chronic Kidney Dis. 2010 Mar;17(2):190-204. (PMID: 20219622) Clin J Am Soc Nephrol. 2006 Jan;1(1):148-57. (PMID: 17699202) Clin Chim Acta. 1972 Mar;37:193-7. (PMID: 5022083) J Nutr. 2007 Jun;137(6):1491-2. (PMID: 17513412) J Am Diet Assoc. 2005 Jan;105(1):110-3. (PMID: 15635355) Food Addit Contam. 1999 Feb;16(2):79-87. (PMID: 10435077) FASEB J. 1989 Dec;3(14):2629-32. (PMID: 2480260) N Engl J Med. 2006 May 18;354(20):2122-30. (PMID: 16707749) Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. (PMID: 17699395) Kidney Int. 2003 Feb;63(2):678-85. (PMID: 12631134) Kidney Int. 2003 Sep;64(3):1035-45. (PMID: 12911554) Am J Kidney Dis. 2001 Nov;38(5):1089-95. (PMID: 11684564) J Am Soc Nephrol. 2002 Nov;13(11):2723-9. (PMID: 12397042) J Food Sci. 2010 Apr;75(3):R77-87. (PMID: 20492310) |
| المشرفين على المادة: | 3G6A5W338E (Caffeine) |
| تواريخ الأحداث: | Date Created: 20120718 Date Completed: 20131119 Latest Revision: 20211021 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC3854321 |
| DOI: | 10.1590/s0100-879x2012007500120 |
| PMID: | 22801417 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1414-431X |
|---|---|
| DOI: | 10.1590/s0100-879x2012007500120 |